XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Beginning balance at Dec. 31, 2020 $ 44,425   $ 331,450 $ (286,073) $ (952)
Beginning balance, Shares at Dec. 31, 2020   53,503,124      
Stock option exercises 1,297   1,297    
Stock option exercises, Shares   676,791      
Issuance of common stock under employee stock purchase plan 418   418    
Issuance of common stock under employee stock purchase plan, Shares   90,796      
Share-based compensation expense 3,632   3,632    
Issuance of common stock to collaboration partners 27,739   27,739    
Issuance of common stock to collaboration partners, Shares   3,762,190      
Net income (loss) (18,689)     (18,689)  
Ending balance at Mar. 31, 2021 58,822   364,536 (304,762) (952)
Ending balance, Shares at Mar. 31, 2021   58,032,901      
Beginning balance at Dec. 31, 2020 44,425   331,450 (286,073) (952)
Beginning balance, Shares at Dec. 31, 2020   53,503,124      
Net income (loss) (8,312)        
Ending balance at Sep. 30, 2021 101,443   396,780 (294,385) (952)
Ending balance, Shares at Sep. 30, 2021   60,892,018      
Beginning balance at Mar. 31, 2021 58,822   364,536 (304,762) (952)
Beginning balance, Shares at Mar. 31, 2021   58,032,901      
Stock option exercises 1,353   1,353    
Stock option exercises, Shares   766,767      
Share-based compensation expense 3,896   3,896    
Proceeds from issuance of common stock, net of issuance cost 14,826   14,826    
Proceeds from issuance of common stock, net of issuance cost, Shares   1,293,754      
Net income (loss) 21,656     21,656  
Ending balance at Jun. 30, 2021 100,553   384,611 (283,106) (952)
Ending balance, Shares at Jun. 30, 2021   60,093,422      
Stock option exercises 3,393   3,393    
Stock option exercises, Shares   414,073      
Issuance of common stock under employee stock purchase plan 386   386    
Issuance of common stock under employee stock purchase plan, Shares   36,091      
Share-based compensation expense 4,551   4,551    
Proceeds from issuance of common stock, net of issuance cost 3,839   3,839    
Proceeds from issuance of common stock, net of issuance cost, Shares   348,432      
Net income (loss) (11,279)     (11,279)  
Ending balance at Sep. 30, 2021 101,443   396,780 (294,385) (952)
Ending balance, Shares at Sep. 30, 2021   60,892,018      
Beginning balance at Dec. 31, 2021 $ 91,168   408,795 (316,675) (952)
Beginning balance, Shares at Dec. 31, 2021 61,712,577 61,712,577      
Stock option exercises $ 340   340    
Stock option exercises, Shares   233,001      
Issuance of common stock under employee stock purchase plan 282   282    
Issuance of common stock under employee stock purchase plan, Shares   78,060      
Share-based compensation expense 4,390   4,390    
Proceeds from issuance of common stock, net of issuance cost 1,647   1,647    
Proceeds from issuance of common stock, net of issuance cost, Shares   561,405      
Net income (loss) (28,168)     (28,168)  
Ending balance at Mar. 31, 2022 69,659   415,454 (344,843) (952)
Ending balance, Shares at Mar. 31, 2022   62,585,043      
Beginning balance at Dec. 31, 2021 $ 91,168   408,795 (316,675) (952)
Beginning balance, Shares at Dec. 31, 2021 61,712,577 61,712,577      
Stock option exercises, Shares 330,359        
Net income (loss) $ (83,149)        
Ending balance at Sep. 30, 2022 $ 84,380 $ 1 485,155 (399,824) (952)
Ending balance, Shares at Sep. 30, 2022 111,745,219 111,745,219      
Beginning balance at Mar. 31, 2022 $ 69,659   415,454 (344,843) (952)
Beginning balance, Shares at Mar. 31, 2022   62,585,043      
Stock option exercises 38   38    
Stock option exercises, Shares   78,234      
Share-based compensation expense 5,138   5,138    
Proceeds from issuance of common stock, net of issuance cost 47,670   47,670    
Proceeds from issuance of common stock, net of issuance cost, Shares   36,274,651      
Issuance of common stock to collaboration partners 11,553   11,553    
Issuance of common stock to collaboration partners, Shares   12,407,440      
Restricted stock units vested, Shares   260,137      
Net income (loss) (31,035)     (31,035)  
Ending balance at Jun. 30, 2022 103,023   479,853 (375,878) (952)
Ending balance, Shares at Jun. 30, 2022   111,605,505      
Stock option exercises 9   9    
Stock option exercises, Shares   19,124      
Issuance of common stock under employee stock purchase plan 161 $ 1 160    
Issuance of common stock under employee stock purchase plan, Shares   116,612      
Share-based compensation expense 5,133   5,133    
Restricted stock units vested, Shares   3,978      
Net income (loss) (23,946)     (23,946)  
Ending balance at Sep. 30, 2022 $ 84,380 $ 1 $ 485,155 $ (399,824) $ (952)
Ending balance, Shares at Sep. 30, 2022 111,745,219 111,745,219